Stock Events

Stock Events

ObsEva SA. 

$0
76
+$0+0% Thursday 16:42

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
2,500
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-152.16%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
19.64MRevenue
-29.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OBSEF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap189.22B
Amgen Inc. competes in the biopharmaceutical sector focusing on treatments in areas that may overlap with ObsEva's reproductive health products.
Merck
MRK
Mkt Cap300.2B
Merck & Co., Inc. offers a broad range of health solutions including women's health, directly competing with ObsEva's portfolio.
Pfizer
PFE
Mkt Cap153.13B
Pfizer Inc. has a diverse range of pharmaceutical products, including those in women's health, making it a competitor.
Novo Nordisk
NVO
Mkt Cap167.44B
Novo Nordisk A/S focuses on hormone replacement therapies and other treatments that can compete with ObsEva's reproductive health products.
Bristol-Myers Squibb
BMY
Mkt Cap119.69B
Bristol-Myers Squibb Company operates in various therapeutic areas, including those that could compete with ObsEva's focus areas.
Abbvie
ABBV
Mkt Cap367.8B
AbbVie Inc. has a strong presence in women's health through its hormonal therapies, competing with ObsEva.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap36.77B
Teva Pharmaceutical Industries Limited offers generic and specialty medicines, including in women's health, posing competition to ObsEva.
Lilly(Eli) &
LLY
Mkt Cap840.84B
Eli Lilly and Company has a portfolio that includes treatments for conditions in women's health, competing with ObsEva.
GSK
GSK
Mkt Cap116.3B
GlaxoSmithKline plc engages in the creation of pharmaceuticals, including those for women's health, making it a competitor.
Sanofi
SNY
Mkt Cap113.88B
Sanofi offers a broad range of healthcare solutions, including in areas that compete with ObsEva's focus on reproductive health.

About

ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women's reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.
Show more...
CEO
Dr. Ernest Loumaye M.D., OB/GYN, Ph.D.
Employees
15
Country
Switzerland
ISIN
CH1260041939

Listings

OTC Link
US
OBSEF

0 Comments

Share your thoughts

FAQ

What is ObsEva SA. stock price today?▼
The current price of OBSEF is $0 USD — it has increased by +0% in the past 24 hours. Watch ObsEva SA. stock price performance more closely on the chart.
What is ObsEva SA. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ObsEva SA. stocks are traded under the ticker OBSEF.
What is ObsEva SA. revenue for the last year?▼
ObsEva SA. revenue for the last year amounts to 19.64M USD.
What is ObsEva SA. net income for the last year?▼
OBSEF net income for the last year is -29.88M USD.
How many employees does ObsEva SA. have?▼
As of April 18, 2026, the company has 15 employees.
In which sector is ObsEva SA. located?▼
ObsEva SA. operates in the Health & Wellness sector.
When did ObsEva SA. complete a stock split?▼
ObsEva SA. has not had any recent stock splits.
Where is ObsEva SA. headquartered?▼
ObsEva SA. is headquartered in Geneva, Switzerland.